Skip to content

For Patients

What is medicinal cannabis?

Medicinal cannabis serves various purposes for different individuals. At SOMAÍ Pharmaceuticals, we endeavor to provide cannabis-based treatment to all required patients through prescriptions given by specialized healthcare experts.

Cannabis utilized for therapeutic purposes within clinical contexts is referred to as a cannabis-based medicinal product, commonly known as ‘medicinal cannabis’. This category encompasses various items such as the complete cannabis flower, capsules, oils, and sprays. Within the cannabis plant, there are more than 120 cannabinoids, with the primary ones being cannabidiol (CBD) and tetrahydrocannabinol (THC). Tailored blends of CBD and THC are formulated to cater to the specific requirements of individual treatments.

Frequently asked questions


Newsletter 2024 05 15T211539.791


May 16, 2024

Recently, there’s been a lot of talk about cannabidiol, a compound found in the Cannabis sativa plant. Unlike…

Read more
Newsletter (2)

SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal

March 12, 2024

SOMAÍ Pharmaceuticals signs distribution deal with Grow Pharma for UK’s most comprehensive range of cannabis-based medicines. This collaboration…

Read more
Newsletter 2024 02 29T155639.107

SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector

February 29, 2024

SOMAÍ Pharmaceuticals today announced it has entered into a definitive agreement with AKANDA Corp., an international medical cannabis…

Read more
Newsletter 92

SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets

February 6, 2024

SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products….

Read more
Newsletter 1920 x 950 px 4

SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany

December 21, 2023

SOMAÍ Pharmaceuticals announces a landmark three-year marketing & distribution agreement with Canify AG. This partnership signifies SOMAÍ Pharmaceuticals’…

Read more
Newsletter 84

SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal

December 14, 2023

SOMAÍ Pharmaceuticals announces its entry into the German market through partnerships with Canymed GmbH and Grünhorn, securing a…

Read More
Newsletter 1200 x 628 px 1200 x 628 px 1920 x 950 px 1

SOMAÍ Pharmaceuticals Partners with UK’s largest medical cannabis study T21 by Drug Science

December 12, 2023

SOMAÍ Pharmaceuticals is thrilled to announce partnering with the groundbreaking medical cannabis study, T21 (formerly Project TWENTY21). As…

read more
Newsletter 82

SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest

November 28, 2023

SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products…

read more
Newsletter 48

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

September 1, 2023

SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has…

Read more

SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development

July 26, 2023

According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also…

Read more
SOMAI IG Size 1920 x 950 px 5

SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Cannabis

June 12, 2023

SOMAÍ Pharmaceuticals has entered into a two-year supply agreement with a well-respected Polish distributor Cosma Cannabis. Cosma produces…

Read more
Untitled design 38

Clever Leaves Partners with SOMAÍ Pharmaceuticals and Sends First Commercial Shipments to Portugal

May 31, 2023

SOMAÍ Pharmaceuticals Unipessoal LDA has entered into a five-year agreement with Clever Leaves Holdings Inc., a global medicinal…

Read more

About Medical Cannabis

What are the key components of medicinal cannabis? Read more

What are the key components of medicinal cannabis?

What is the story behind Medicinal cannabis? Read more

What is the story behind Medicinal cannabis?

How does the endocannabinoid system work? Read more

How does the endocannabinoid system work?

Cannabinoids and the endocannabinoid system Read more

Cannabinoids and the endocannabinoid system

What does the medicinal cannabis landscape look like today? Read more

What does the medicinal cannabis landscape look like today?

Safety of medicinal cannabis and its side effects Read more

Safety of medicinal cannabis and its side effects